🎁 💸 Warren Buffett's Top Picks Are Up +49.1%. Copy Them to Your Watchlist – For FreeCopy Portfolio

CASMED reports preliminary Q4 revenue; shares +14%

Published 01/04/2018, 12:01 PM
© Reuters.  CASMED reports preliminary Q4 revenue; shares +14%
CASM
-
MNKKQ
-
  • CAS Medical Systems (NASDAQ:CASM) expects net sales from continuing operations for the Q417 to be ~$5.1M (+11% Y/Y) vs. a consensus of $4.53M.
  • Net sales for the FY17 are expected to ~$18.7M (flat Y/Y) vs. a consensus of $18.46M.
  • The Company’s year-end cash balance plus cash available under its line of credit was ~$7.4M.
  • Expected FORE-SIGHT® highlights for the Q417 vs. Q416.
  • U.S. FORE-SIGHT cerebral oximetry sales increased 18% (y/y) to ~$4.3M, driven by strong monitor sales, and an 8% increase in U.S. FORE-SIGHT sensor sales.
  • A net 110 FORE-SIGHT cerebral oximeters were shipped to new and existing customers worldwide, driven by a record net 80 monitors shipped in the U.S.
  • The installed base of U.S. monitors grew to 1,318 (+17.67% Y/Y) as of Dec. 31, 2017.
  • Total FORE-SIGHT sales increased 12% to ~$5.0M.
  • Press Release
  • Now read: Mallinckrodt (NYSE:MNK): Recent Insider Buying Sending A Buy Signal?


Original article

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.